搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
labiotech
4 天
ADCs that deliver: The secret lies in rigorous characterization
Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective ...
8 天
昆明植物所呼吁抢救性保护和可持续利用抗癌植物假柴龙树属的所有 ...
喜树碱是一种主要由假柴龙树属(茶茱萸科)、喜树(蓝果树科)、蛇根草属(茜草科)等植物类群产生的用于化学防御的单萜喹啉类生物碱,其通过抑制DNA拓扑异构酶I和诱导癌细胞dsDNA断裂,在治疗肺癌、肠癌等癌症方面表现出良好的抗癌活性,是继紫杉醇和长春花生 ...
10 小时
NMN And NAD: Hot Topics In Beauty And Longevity
If Jennifer Aniston thinks NAD is the future, then Baran Dilaver, founder of Wonderfeel, believes the future is now.
Targeted Oncology
1 天
Integrating Immunotherapy Into Frontline ALL Treatment
In an interview with Targeted Oncology, Mark R. Litzow, MD, discussed the incorporation of Immunotherapy into upfront acute ...
The EMBO Journal
5 天
Goliath, meet David
K Heran Darwin is at New York University Grossman School of Medicine and a regular columnist for EMBO reports.
15 天
ESMO 2024 | 消化系统肿瘤领域LBA和Oral一文汇总
2024年9月13日-17日,欧洲肿瘤内科学会(ESMO)年会将于在西班牙巴塞罗那召开,作为肿瘤内科最高规模的国际盛会,涉及肺癌、乳腺癌、消化道肿瘤、泌尿生殖系统肿瘤等领域的多项研究届时皆将披露最新进展。
News Medical on MSN
7 天
ESMO: Novel ADC AZD8205 demonstrates manageable safety profile and preliminary efficacy in ...
The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with ...
8 天
on MSN
Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Cold Play
Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our ...
Opinion
The Westerly Sun
2 天
Opinion
Embracing Multiculturalism: Love creates, extends families, communities
Witnessing Vice President Kamala Harris accept the Democratic presidential nomination and hearing her share her experience of ...
Pharmaceutical Technology
13 天
Risk adjusted net present value: What is the current valuation of AbbVie’s Pivekimab ...
Pivekimab sunirine is a monoclonal antibody conjugated commercialized by AbbVie, with a leading Phase II program in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia).
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈